Search results
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters· 12 hours agoGlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of...
What's Going On With Pfizer Stock On Thursday? By Benzinga
Investing.com· 8 hours agoWhat's Going On With Pfizer Stock On Thursday?
BioNTech SE to Post Q1 2024 Earnings of $1.26 Per Share, HC Wainwright Forecasts (NASDAQ:BNTX)
ETF DAILY NEWS· 4 days agoBioNTech SE (NASDAQ:BNTX – Free Report) – Stock analysts at HC Wainwright issued their Q1 2024 earnings per share (EPS) estimates for shares of BioNTech ...
BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
Morningstar· 4 days agoBioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2024 on Monday, May 6, 2024. Additionally ...
GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales
Bloomberg Law· 9 hours agohave reported from sales of their Covid-19 vaccines, which GSK alleges infringe five patents related to mRNA vaccine technology. The complaint relates to patents discovered by researchers who ...
Brokerages Set BioNTech SE (NASDAQ:BNTX) PT at $120.40
ETF DAILY NEWS· 7 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) has been assigned a consensus recommendation of “Hold” from the ten ratings firms that are currently covering ...
25 Richest Billionaires in Healthcare Industry
Insider Monkey via Yahoo Finance· 3 days agoIn this article, we discuss the 25 richest billionaires in healthcare industry. To skip the detailed analysis of the healthcare industry, go directly to...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 2 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Reuters· 3 days agoPfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to...
HC Wainwright Reaffirms “Buy” Rating for BioNTech (NASDAQ:BNTX)
ETF DAILY NEWS· 7 days agoBioNTech (NASDAQ:BNTX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research note issued to investors on Wednesday, Benzinga reports. Several other ...